120 related articles for article (PubMed ID: 35547599)
1. Erratum: Baseline Serum Cholesterol Levels Predict the Response of Patients with Advanced Non-Small Cell Lung Cancer to Immune Checkpoint Inhibitor-Based Treatment [Corrigendum].
Cancer Manag Res; 2022; 14():1653-1654. PubMed ID: 35547599
[TBL] [Abstract][Full Text] [Related]
2. Erratum: Pre-Existing Diabetes Limits Survival Rate After Immune Checkpoint Inhibitor Treatment for Advanced Lung Cancer: A Retrospective Study in Japan [Corrigendum].
Diabetes Metab Syndr Obes; 2021; 14():3109. PubMed ID: 34262314
[TBL] [Abstract][Full Text] [Related]
3. Erratum: Sp1 Contributes to Radioresistance of Cervical Cancer Through Targeting G2/M Cell Cycle Checkpoint CDK1 [Corrigendum].
Cancer Manag Res; 2021; 13():8525-8526. PubMed ID: 34849021
[TBL] [Abstract][Full Text] [Related]
4. Erratum: IL-33 Promotes the Growth of Non-Small Cell Lung Cancer Cells Through Regulating miR-128-3p/CDIP1 Signalling Pathway [Corrigendum].
Cancer Manag Res; 2021; 13():2907. PubMed ID: 33833573
[TBL] [Abstract][Full Text] [Related]
5. Erratum: Integrative Gene Expression Profiling Reveals That Dysregulated Triple microRNAs Confer Paclitaxel Resistance in Non-Small Cell Lung Cancer via Cotargeting MAPT [Corrigendum].
Cancer Manag Res; 2020; 12():12915-12916. PubMed ID: 33364839
[TBL] [Abstract][Full Text] [Related]
6. Erratum: Nomogram to Predict Distant Metastasis Probability for Pathological Complete Response Rectal Cancer Patients After Neoadjuvant Chemoradiotherapy [Corrigendum].
Cancer Manag Res; 2022; 14():2533-2534. PubMed ID: 36060215
[TBL] [Abstract][Full Text] [Related]
7. Baseline Serum Cholesterol Levels Predict the Response of Patients with Advanced Non-Small Cell Lung Cancer to Immune Checkpoint Inhibitor-Based Treatment.
Tong J; Mao Y; Yang Z; Xu Q; Zheng Z; Zhang H; Wang J; Zhang S; Rong W; Zheng L
Cancer Manag Res; 2021; 13():4041-4053. PubMed ID: 34040444
[TBL] [Abstract][Full Text] [Related]
8. Erratum: Impact of the Time Interval Between Primary Debulking Surgery and Start of Adjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer [Corrigendum].
Cancer Manag Res; 2021; 13():6363-6364. PubMed ID: 34408495
[TBL] [Abstract][Full Text] [Related]
9. Erratum: Large Scale, Multicenter, Prospective Study of Apatinib in Advanced Gastric Cancer: A Real-World Study from China [Corrigendum].
Cancer Manag Res; 2020; 12():8409. PubMed ID: 32982434
[TBL] [Abstract][Full Text] [Related]
10. Erratum: The Development of a Nomogram to Predict Post-Radiation Necrosis in Nasopharyngeal Carcinoma Patients: A Large-Scale Cohort Study [Corrigendum].
Cancer Manag Res; 2020; 12():1371. PubMed ID: 32161491
[TBL] [Abstract][Full Text] [Related]
11. Erratum: Palliative Gastrectomy Plus Chemotherapy versus Chemotherapy Alone for Incurable Advanced Gastric Cancer: A Meta-Analysis [Corrigendum].
Cancer Manag Res; 2024; 16():71-72. PubMed ID: 38293291
[TBL] [Abstract][Full Text] [Related]
12. Erratum: The Efficacy and Safety of Apatinib in Advanced Synovial Sarcoma: A Case Series of Twenty-One Patients in One Single Institution [Corrigendum].
Cancer Manag Res; 2020; 12():8079. PubMed ID: 32943939
[TBL] [Abstract][Full Text] [Related]
13. Erratum: lncRNA TM4SF1-AS1 Activates the PI3K/AKT Signaling Pathway and Promotes the Migration and Invasion of Lung Cancer Cells [Corrigendum].
Cancer Manag Res; 2020; 12():8055. PubMed ID: 32982403
[TBL] [Abstract][Full Text] [Related]
14. Erratum: Intraoperative Prediction of Non-Sentinel Lymph Node Metastasis Based on the Molecular Assay in Breast Cancer Patients [Corrigendum].
Cancer Manag Res; 2020; 12():1875. PubMed ID: 32214845
[TBL] [Abstract][Full Text] [Related]
15. Erratum: Prognostic Role of a New Inflammatory Index with Neutrophil-to-Lymphocyte Ratio and Lactate Dehydrogenase (CII: Colon Inflammatory Index) in Patients with Metastatic Colorectal Cancer: Results from the Randomized Italian Trial in Advanced Colorectal Cancer (ITACa) Study [Corrigendum].
Cancer Manag Res; 2020; 12():541. PubMed ID: 32021463
[TBL] [Abstract][Full Text] [Related]
16. Erratum: Analysis of Mono-ADP-Ribosylation Levels in Human Colorectal Cancer [Corrigendum].
Cancer Manag Res; 2021; 13():4967. PubMed ID: 34188549
[TBL] [Abstract][Full Text] [Related]
17. Erratum: Family Wellbeing and Sexual Health of Patients Receiving Treatment for Prostate Cancer [Corrigendum].
Cancer Manag Res; 2023; 15():1319-1320. PubMed ID: 38027236
[TBL] [Abstract][Full Text] [Related]
18. Erratum: Circulating miRNAs as Potential Biomarkers in Prostate Cancer Patients Undergoing Radiotherapy [Corrigendum].
Cancer Manag Res; 2022; 14():409-410. PubMed ID: 35140518
[TBL] [Abstract][Full Text] [Related]
19. Erratum: Validation of the Chinese Version of the Shame and Stigma Scale in Patients with Head and Neck Cancer [Corrigendum].
Cancer Manag Res; 2020; 12():4957. PubMed ID: 32617018
[TBL] [Abstract][Full Text] [Related]
20. Erratum: The Blood Biomarkers of Thyroid Cancer [Corrigendum].
Cancer Manag Res; 2022; 14():49-50. PubMed ID: 35023970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
